TrialJournal of cancer research and clinical oncology2008

Oral versus intravenous ibandronic acid: a comparison of treatment options for metastatic bone disease.

Kyriaki Mystakidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.